PRISMA

PRISMA is an evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. PRISMA primarily focuses on the reporting of reviews evaluating the effects of interventions, but can also be used as a basis for reporting systematic reviews with objectives other than evaluating interventions (e.g. evaluating aetiology, prevalence, diagnosis or prognosis).

News Feed

PRISMA Website re-design

The PRISMA website underwent a much-needed update in October 2015 to update the content of the website. We have updated the look of the site and added the PRISMA extensions, translations, and information about review protocols.

PRISMA Extensions!

Several PRISMA extensions have been published in 2015 so far.

PRISMA-P for developing review protocols was published in January 2015 in Systematic Reviews and the BMJ.
PRISMA-IPD (individual patient data) was published in JAMA in April
PRISMA-NMA (Network Meta-Analyses) was published in Annals of Internal Medicine in June

These are in addition to the PRISMA Abstract and Equity extensions, all found on the PRISMA website, here.

Welcome to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) website!

Who should use PRISMA?

News Feed

PRISMA Website re-design

PRISMA Extensions!

Key Documents